MedTrace Logo

MRI-Guided Bladder Preservation Program For Patients With Muscle Invasive Bladder Cancer

NCT07026864 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2025-08-24

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if the use of MRI-guided irradiation increases the rates of bladder preservation as well as to decrease complications in patients with muscle invasive bladder cancer who wish to retain their bladders

Conditions

  • Muscle Invasive Bladder Cancer (MIBC)

Interventions

RADIATION

MR-guided Radiation Therapy

MR-guided Radiation Therapy

Sponsors & Collaborators

  • Clinica Universidad de Navarra, Universidad de Navarra

    lead OTHER

Principal Investigators

  • Rafael Martínez-Monge, M.D. · Clínica Universidad de Navarra

  • Marta Moreno-Jiménez, M.D. · Clínica Universidad de Navarra

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-01
Primary Completion
2030-07-01
Completion
2030-07-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07026864 on ClinicalTrials.gov